Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1

Status

Completed 8Unknown 7Terminated 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3Observational 1

Sponsor

Conditions

Leiomyoma 3Menorrhagia 1

Interventions

Cyclophosphamide 389Carboplatin 343Gemcitabine 331pembrolizumab 328Cisplatin 327Paclitaxel 294Radiotherapy 291Docetaxel 285Bevacizumab 249Rituximab 233Capecitabine 221Nivolumab 218Dexamethasone 205Fluorouracil 189fludarabine 177Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 133Bortezomib 129fludarabine phosphate 128Cetuximab 126Lenalidomide 125Filgrastim 119Erlotinib Hydrochloride 119Temozolomide 111Radiosurgery 110

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Terminated × Interventional × ulipristal acetate × Clear all
NCT02425878 2020-10-14

Ulipristal Acetate 10 mg and Asisted Reproduction

Instituto Valenciano de Infertilidad, IVI VALENCIA

Phase 3 Terminated
2 enrolled

Leiomyoma

NCT04132349 2020-04-13

Ulipristal Acetate in Symptomatic Uterine Fibroid

Mỹ Đức Hospital

Phase 4 Terminated
25 enrolled

Leiomyoma, Menorrhagia

NCT02825719 2020-04-09

Ulipristal Use in Chinese Population

Queen Mary Hospital, Hong Kong

Phase 4 Terminated
31 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡